← Back to patent-cliff list
CAS 17469-89-5
N,N-dimethyl-L-phenylalanine
Codes: MB07133-002
Application context (from source-drug indications)
Liver cancerPracytarabineHepatocellular carcinomaPracytarabine线粒体疾病PracytarabineCholangiocarcinomaPracytarabine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Pracytarabine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(E)-N'-(1-((2R,3S,4R,5R)-3,4-bis((tert-butyldimethylsilyl)oxy)-5-((((2R,4S)-2-oxido-4-(pyridin-4-yl)-1,3,2-dioxaphosphinan-2-yl)oxy)methyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)-N,N-dimethylformimidamide→ethyl 3-hydroxy-3-(pyridin-4-yl)propanoate→N,N-dimethyl-L-phenylalanine→(S)-3-ethoxy-3-oxo-1-(pyridin-4-yl)propyl dimethyl-L-phenylalaninate→(S)-1-(pyridin-4-yl)propane-1,3-diol→4-nitrophenyl phosphorodichloridate→(2S,4S)-2-(4-nitrophenoxy)-4-(pyridin-4-yl)-1,3,2-dioxaphosphinane 2-oxide→(E)-N'-(1-((2R,3S,4R,5R)-3,4-bis((tert-butyldimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)-N,N-dimethylformimidamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.